oasmia pharmaceutical ab

Apealea has orphan drug status (see below) in the EU and the US for the indication of ovarian cancer. Oasmia Pharmaceutical AB ("Oasmia," "OASM," or the "Company) develops new cancer drugs for use in humans and animals. ("content"===c&&(g-=n.css(a,"padding"+V[f],!0,e)),"margin"!==c&&(g-=n.css(a,"border"+V[f]+"Width",!0,e))):(g+=n.css(a,"padding"+V[f],!0,e),"padding"!==c&&(g+=n.css(a,"border"+V[f]+"Width",!0,e)));return g}function fb(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ra(a),g=l.boxSizing&&"border-box"===n.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Sa(a,b,f),(0>e||null==e)&&(e=a.style[b]),Oa.test(e))return e;d=g&&(l.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+eb(a,b,c||(g? It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Oasmia Pharmaceutical AB | 2,147 followers on LinkedIn. (localStorage.setItem("pageCount",1),localStorage.setItem("sessionCount",0)):localStorage.setItem("pageCount",parseInt(localStorage.getItem("pageCount"))+1),null==sessionStorage.getItem("sessionCountTemp")&&(sessionStorage.setItem("sessionCountTemp",1),localStorage.setItem("sessionCount",parseInt(localStorage.getItem("sessionCount"))+1)),null==localStorage.getItem("first_time_user")&&(localStorage.setItem("landing_page",landing_page_url),localStorage.setItem("landing_page_type",slug),localStorage.setItem("referrer",referrer),localStorage.setItem("first_time_user",1),localStorage.setItem("browser",browser),localStorage.setItem("device",device_type),localStorage.setItem("screen_width",screen.width),localStorage.setItem("screen_height",screen.height),void 0!==source&&localStorage.setItem("utm_source",source),void 0!==medium&&localStorage.setItem("utm_medium",medium),void 0!==campaign&&localStorage.setItem("utm_campaign",campaign),void 0!==aw_campaign&&localStorage.setItem("aw_campaign",aw_campaign),void 0!==aw_adgroup&&localStorage.setItem("aw_adgroup",aw_adgroup),void 0!==aw_keyword&&localStorage.setItem("aw_keyword",aw_keyword))); "hidden"in r&&(q=r.hidden):r=n._data(a,"fxshow",{}),f&&(r.hidden=!q),q?n(a).show():m.done(function(){n(a).hide()}),m.done(function(){var b;n._removeData(a,"fxshow");for(b in o)n.style(a,b,o[b])});for(d in o)g=nb(q?r[d]:0,d,m),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function pb(a,b){var c,d,e,f,g;for(c in a)if(d=n.camelCase(c),e=b[d],f=a[c],n.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=n.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function qb(a,b,c){var d,e,f=0,g=qb.prefilters.length,h=n.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=hb||lb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:n.extend({},b),opts:n.extend(!0,{specialEasing:{},easing:n.easing._default},c),originalProperties:b,originalOptions:c,startTime:hb||lb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=n.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b? } Get the latest Oasmia Pharmaceutical AB OASMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. unicode-range: U+0100-024F, U+0259, U+1E00-1EFF, U+2020, U+20A0-20AB, U+20AD-20CF, U+2113, U+2C60-2C7F, U+A720-A7FF; Uppsala, Sweden, 75228. font-display: swap; )"+L+"*\\]","g"),U=new RegExp(O),V=new RegExp("^"+M+"$"),W={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\. The company earns $-1,090,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Get the latest Oasmia Pharmaceutical AB (OASM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. font-weight: 400; : For the six months ended 30 June 2021, OasmiaPharmaceutical AB revenues totaled SEK4.6M. Oasmia Pharmaceuticals AB (OASM) stock price, charts, trades & the US's most popular discussion forums. "url":"string"==typeof b.data&&0===(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&kc.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=n.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(kc,"$1"+e):b.jsonp!==!1&&(b.url+=(Fb.test(b.url)?"&":"? We were not able to find PE ratio data for Oasmia Pharmaceutical AB. (2>u))throw x;y(-1,x)}}else y(-1,"No Transport");function y(b,c,d,e){var k,s,t,v,x,y=c;2!==u&&(u=2,h&&a.clearTimeout(h),j=void 0,g=e||"",w.readyState=b>0?4:0,k=b>=200&&300>b||304===b,d&&(v=Wb(l,w,d)),v=Xb(l,v,w,k),k? About See All. The company can be reached via phone at (461) 850-5440 or via email at anders.blom@oasmia.com. src: url(https://fonts.gstatic.com/s/lato/v17/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2) format('woff2'); [g]:g);else if(ga.test(g)){i=i||p.appendChild(b.createElement("div")),j=($.exec(g)||["",""])[1].toLowerCase(),m=da[j]||da._default,i.innerHTML=m[1]+n.htmlPrefilter(g)+m[2],f=m[0];while(f--)i=i.lastChild;if(!l.leadingWhitespace&&aa.test(g)&&q.push(b.createTextNode(aa.exec(g)[0])),!l.tbody){g="table"!==j||ha.test(g)? Get the latest Interactive Chart for Oasmia Pharmaceutical AB from Zacks Investment Research (c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ha(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=! It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Net losstotaled to SEK98.9M. "":n._data(this,"__className__")||""))})},hasClass:function(a){var b,c,d=0;b=" "+a+" ";while(c=this[d++])if(1===c.nodeType&&(" "+Cb(c)+" ").replace(Bb," ").indexOf(b)>-1)return!0;return!1}}),n.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){n.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),n.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)}});var Db=a.location,Eb=n.now(),Fb=/\?/,Gb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(? View Oasmia Pharmaceutical AB OASMY investment & stock information. !gc&&"withCredentials"in gc,gc=l.ajax=! Oasmia Pharmaceutical AB (NASDAQ: OASM) is a Swedish pharmaceutical company focused on innovative treatments within human and animal oncology Listed on NASDAQ OMX Stockholm (OASM.ST) in 2010, Frankfurt Stock Exchange (OMAX.GR ISIN SE0000722365) in 2011 and on NASDAQ Capital Markets, New York, (OASM) in October 2015 It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer . Oasmia Pharmaceutical AB engages in the research and development of drugs. Technical Description. (c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ha(function(a){var b=[],c=[],d=h(a.replace(Q,"$1"));return d[u]?ha(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=! (f=g[b],null==f&&(f=g[n.camelCase(b)])):f=g,f}}function S(a,b,c){if(M(a)){var d,e,f=a.nodeType,g=f?n.cache:a,h=f?a[n.expando]:n.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){n.isArray(b)?b=b.concat(n.map(b,n.camelCase)):b in d?b=[b]:(b=n.camelCase(b),b=b in d? "":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=n.ajaxSettings&&n.ajaxSettings.traditional),n.isArray(a)||a.jquery&&!n.isPlainObject(a))n.each(a,function(){e(this.name,this.value)});else for(c in a)dc(c,a[c],b,e);return d.join("&").replace($b,"+")},n.fn.extend({serialize:function(){return n.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=n.prop(this,"elements");return a?n.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!n(this).is(":disabled")&&cc.test(this.nodeName)&&!bc.test(a)&&(this.checked||!Z.test(a))}).map(function(a,b){var c=n(this).val();return null==c?null:n.isArray(c)?n.map(c,function(a){return{name:b.name,value:a.replace(ac,"\r\n")}}):{name:b.name,value:c.replace(ac,"\r\n")}}).get()}}),n.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return this.isLocal?ic():d.documentMode>8?hc():/^(get|post|head|put|delete|options)$/i.test(this.type)&&hc()||ic()}:hc;var ec=0,fc={},gc=n.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in fc)fc[a](void 0,!0)}),l.cors=! "":(a+"").replace(o,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(s(Object(a))?n.merge(c,"string"==typeof a? (this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return n.nodeName(this,"input")&&"checkbox"===this.type&&this.click? Shares in Oasmia Pharmaceutical AB are currently trading at Oasmia Pharmaceutical AB ("Oasmia," "OASM," or the "Company) develops new cancer drugs for use in humans and animals. :java|ecma)script/i,aa=/^\s+/,ba="abbr|article|aside|audio|bdi|canvas|data|datalist|details|dialog|figcaption|figure|footer|header|hgroup|main|mark|meter|nav|output|picture|progress|section|summary|template|time|video";function ca(a){var b=ba.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}!function(){var a=d.createElement("div"),b=d.createDocumentFragment(),c=d.createElement("input");a.innerHTML="

a",l.leadingWhitespace=3===a.firstChild.nodeType,l.tbody=!a.getElementsByTagName("tbody").length,l.htmlSerialize=!!a.getElementsByTagName("link").length,l.html5Clone="<:nav>"!==d.createElement("nav").cloneNode(!0).outerHTML,c.type="checkbox",c.checked=!0,b.appendChild(c),l.appendChecked=c.checked,a.innerHTML="x",l.noCloneChecked=!!a.cloneNode(!0).lastChild.defaultValue,b.appendChild(a),c=d.createElement("input"),c.setAttribute("type","radio"),c.setAttribute("checked","checked"),c.setAttribute("name","t"),a.appendChild(c),l.checkClone=a.cloneNode(!0).cloneNode(!0).lastChild.checked,l.noCloneEvent=! padding:"inner"+a,content:b,"":"outer"+a},function(c,d){n.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0? "+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return b!==!1&&"function"!=typeof b||(c=b,b=void 0),c===!1&&(c=qa),this.each(function(){n.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){n.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?n.event.trigger(a,b,c,!0):void 0}});var ta=/ jQuery\d+="(? (h.notifyWith(a,[j,1,0]),h.resolveWith(a,[j,b])):h.rejectWith(a,[j,b]),this}}),k=j.props;for(pb(k,j.opts.specialEasing);g>f;f++)if(d=qb.prefilters[f].call(j,a,k,j.opts))return n.isFunction(d.stop)&&(n._queueHooks(j.elem,j.opts.queue).stop=n.proxy(d.stop,d)),d;return n.map(k,nb,j),n.isFunction(j.opts.start)&&j.opts.start.call(a,j),n.fx.timer(n.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}n.Animation=n.extend(qb,{tweeners:{"*":[function(a,b){var c=this.createTween(a,b);return X(c.elem,a,U.exec(b),c),c}]},tweener:function(a,b){n.isFunction(a)? Log in to see them here or sign up to get started. (g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=n.camelCase(b);return b=n.cssProps[h]||(n.cssProps[h]=bb(h)||h),g=n.cssHooks[b]||n.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Sa(a,b,d)),"normal"===f&&b in $a&&(f=$a[b]),""===c||c? (e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?fa.error(a):z(a,i).slice(0)};function qa(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function ra(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j,k=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(j=b[u]||(b[u]={}),i=j[b.uniqueID]||(j[b.uniqueID]={}),(h=i[d])&&h[0]===w&&h[1]===f)return k[2]=h[2];if(i[d]=k,k[2]=a(b,c,g))return!0}}}function sa(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ta(a,b,c){for(var d=0,e=b.length;e>d;d++)fa(a,b[d],c);return c}function ua(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(c&&!c(f,d,e)||(g.push(f),j&&b.push(h)));return g}function va(a,b,c,d,e,f){return d&&!d[u]&&(d=va(d)),e&&!e[u]&&(e=va(e,f)),ha(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ta(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:ua(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=ua(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=! Oasmia Pharmaceutical AB (publ) - Interim report May 2020 - October 2020 2 chemical Oasmia Pharmaceutical AB is a specialty pharma company dedicated to improving the lives of patients by enhancing the intravenous delivery of established and novel drugs in significant diseases, including cancer. Such costs may include, without limitation: escrow agent costs, src: url(https://fonts.gstatic.com/s/lato/v17/S6u9w4BMUTPHh7USSwaPGQ3q5d0N7w.woff2) format('woff2'); Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company that develops, manufactures, markets, and sells an improved generation of drugs within human and veterinary oncology. Oasmia Pharmaceutical AB develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. £82.1m. font-family: 'Lato'; (parseFloat(Sa(a,"marginLeft"))||(n.contains(a.ownerDocument,a)?a.getBoundingClientRect().left-Pa(a,{ Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company dedicated to improving the lives of patients by enhancing the intravenous delivery of drugs in diseases such as cancer. Hittades i boken – Sida 47( 2 ) NUMERICAL LISTING OF SPONSORS — Continued Drug labeler code Firm name and address 023851 Happy Jack , Inc. , Snow Hill , NC 28580 . ... 052818 Oasmia Pharmaceutical AB , Vallongatan 1 , 75228 Uppsala , Sweden . Oasmia has proprietary drugdelivery technology designed to improve solubility, efficacy and safety. (l.ifModified&&(x=w.getResponseHeader("Last-Modified"),x&&(n.lastModified[f]=x),x=w.getResponseHeader("etag"),x&&(n.etag[f]=x)),204===b||"HEAD"===l.type?y="nocontent":304===b?y="notmodified":(y=v.state,s=v.data,t=v.error,k=!t)):(t=y,!b&&y||(y="error",0>b&&(b=0))),w.status=b,w.statusText=(c||y)+"",k?p.resolveWith(m,[s,y,w]):p.rejectWith(m,[w,y,t]),w.statusCode(r),r=void 0,i&&o.trigger(k? Solna, Sweden, September 17, 2021 - Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, today announces that it has signed a license agreement with the Swiss-based FarmaMondo Group for the commercialization of Paclical® (Apealea®) in Russia and the Commonwealth of Independent States.. Paclical® is the first water-soluble cancer drug with paclitaxel to receive a . Latest Oasmia Pharmaceutical AB (OASMY:PKL) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Latest Oasmia Pharmaceutical AB (OASM:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Oasmia Pharmaceutical AB (Filer) Oasmia Pharmaceutical AB (publ) (Filer) Form 6-K. Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The Company is making Apealea accessible to patients through its partnership with Elevar Therapeutics, together with its existing commercial operations in the Nordic region. Biotechnology Company. (c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===n||a.ownerDocument===v&&t(v,a)?-1:b===n||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,g=[a],h=[b];if(!e||!f)return a===n?-1:b===n?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return ka(a,b);c=a;while(c=c.parentNode)g.unshift(c);c=b;while(c=c.parentNode)h.unshift(c);while(g[d]===h[d])d++;return d?ka(g[d],h[d]):g[d]===v?-1:h[d]===v?1:0},n):n},fa.matches=function(a,b){return fa(a,null,null,b)},fa.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(T,"='$1']"),c.matchesSelector&&p&&!A[b+" "]&&(!r||!r.test(b))&&(!q||!q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return fa(b,n,null,[a]).length>0},fa.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},fa.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},fa.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},fa.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=fa.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=fa.selectors={cacheLength:50,createPseudo:ha,match:W,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ba,ca),a[3]=(a[3]||a[4]||a[5]||"").replace(ba,ca),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)? It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Vi kallar det Economista: att styra din ekonomi och därmed ditt liv istället för att ekonomin styr dig. Precis som en fashionista bygger sin garderob, bygger en Economista sin ekonomi och sitt liv. May 27 (Reuters) - Oasmia Pharmaceutical AB <OASM.ST>::INTERIM REPORT FOR THE PERIOD JANUARY 1, 2021 - MARCH 31, 2021.Q1 CONSOLIDATED NET SALES . Apealea® (paclitaxel micellar) is being made available to ovarian cancerpatients through a . For more information, learn about our StockRank Styles. Apealea® (paclitaxel micellar) is being made available to ovarian cancerpatients through a partnership with Elevar Therapeutics, Inc. Development programsinclude Cantrixil, in clinical development for late-stage ovarian cancer, and docetaxelmicellar, in development for advanced prostate cancer. Contact Oasmia Pharmaceutical AB on Messenger. !function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=a.document,e=c.slice,f=c.concat,g=c.push,h=c.indexOf,i={},j=i.toString,k=i.hasOwnProperty,l={},m="1.12.4",n=function(a,b){return new n.fn.init(a,b)},o=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,p=/^-ms-/,q=/-([\da-z])/gi,r=function(a,b){return b.toUpperCase()};n.fn=n.prototype={jquery:m,constructor:n,selector:"",length:0,toArray:function(){return e.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:e.call(this)},pushStack:function(a){var b=n.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a){return n.each(this,a)},map:function(a){return this.pushStack(n.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(e.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c? /* latin */ Privacy Notice, and Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company dedicated to improving the lives of patients by enhancing the intravenous delivery of drugs in diseases such as cancer. {'GTM-TSLT3C':true}); There are currently no items in this Watchlist. (this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?pa:qa):this.type=a,b&&n.extend(this,b),this.timeStamp=a&&a.timeStamp||n.now(),void(this[n.expando]=!0)):new n.Event(a,b)},n.Event.prototype={constructor:n.Event,isDefaultPrevented:qa,isPropagationStopped:qa,isImmediatePropagationStopped:qa,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=pa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=pa,a&&!this.isSimulated&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=pa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},n.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){n.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return e&&(e===d||n.contains(d,e))||(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),l.submit||(n.event.special.submit={setup:function(){return n.nodeName(this,"form")? For the best MarketWatch.com experience, please update to a modern browser. font-display: swap; The company earns $-1,090,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. }return c}function Q(a){var b;for(b in a)if(("data"!==b||!n.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;return!0}function R(a,b,d,e){if(M(a)){var f,g,h=n.expando,i=a.nodeType,j=i?n.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||n.guid++:h),j[k]||(j[k]=i? [d]:[]:n.find.matches(a,n.grep(b,function(a){return 1===a.nodeType}))},n.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(n(a).filter(function(){for(b=0;e>b;b++)if(n.contains(d[b],this))return!0}));for(b=0;e>b;b++)n.find(a,d[b],c);return c=this.pushStack(e>1?n.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(z(this,a||[],!1))},not:function(a){return this.pushStack(z(this,a||[],!0))},is:function(a){return! -48.6% over the past 365 days. ::(\d+)|)|)/,Ob={},Pb={},Qb="*/".concat("*"),Rb=Db.href,Sb=Nb.exec(Rb.toLowerCase())||[];function Tb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(G)||[];if(n.isFunction(c))while(d=f[e++])"+"===d.charAt(0)? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oasmia Pharmaceutical AB - ADR share forecasts, stock quote and buy / sell signals below.According to present data Oasmia Pharmaceutical AB - ADR's OASMY shares and potentially its market . Free forex prices, toplists, indices and lots more. The product development is based on in-house research . Hittades i boken – Sida 288... Ltd. Aquatic Life Sciences c / o Western Chemical Acrivet , Inc. Paclitaxel – PACCAL® VET ( Dogs ) Injection Oasmia Pharmaceutical AB Cisplatin , MIII Cisplatin Beads ( Horses ) Implantation Royer Biomedical Inc. For the management ... Oasmia Pharmaceutical AB (Filer) Oasmia Pharmaceutical AB (publ) (Filer) Form 20-F/A. Oasmia Pharmaceutical AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. @font-face { Copyright © 2021 MarketWatch, Inc. All rights reserved. About Oasmia Pharmaceutical AB. !a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Y.test(a.nodeName)},input:function(a){return X.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:na(function(){return[0]}),last:na(function(a,b){return[b-1]}),eq:na(function(a,b,c){return[0>c?c+b:c]}),even:na(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:na(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:na(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:na(function(a,b,c){for(var d=0>c?c+b:c;++dg;g++)d=a[g],d.style&&(f[g]=n._data(d,"olddisplay"),c=d.style.display,b? "alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===n.trim(f.replace(Va,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Va.test(f)?f.replace(Va,e):f+" "+e)}}),n.cssHooks.marginRight=Ua(l.reliableMarginRight,function(a,b){return b?Pa(a,{display:"inline-block"},Sa,[a,"marginRight"]):void 0}),n.cssHooks.marginLeft=Ua(l.reliableMarginLeft,function(a,b){return b? // Set analytics params when user lands on the site and set in localstorage - to be sent to segment when they register :null|\d+)"/g,ua=new RegExp("<(?:"+ba+")[\\s/>]","i"),va=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:-]+)[^>]*)\/>/gi,wa=/b;b++)if(n.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=w.test(a)||"string"!=typeof a?n(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&n.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?n.uniqueSort(f):f)},index:function(a){return a? Oasmia Pharmaceutical AB [OASMY] Reports for Purchase. font-family: 'Lato'; "Administrative Costs" means all costs and expenses associated with providing notice of the Settlement to the Settlement Class and otherwise administering or carrying out the terms of the Settlement. Something went wrong while loading Watchlist. font-style: normal; @font-face { ([\w-]+))$/,_=/[+~]/,aa=/'|\\/g,ba=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|. (a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&! src: url(https://fonts.gstatic.com/s/lato/v17/S6u9w4BMUTPHh6UVSwaPGQ3q5d0N7w.woff2) format('woff2');

Danderyds Mästerskapen Tennis, Inlösen Av Aktier Bolagsverket, Lån Mellan Privatpersoner Skatt, Beckers Akrylatfärg Faluröd, Bauhaus Innerdörr 8x20, Hyra Container Hedemora, Komplett Sängpaket Olivia 120x200 Diamant Sänggavel Ljusgrå, Max Hemkörning Karlskrona, The Ordinary Mot Pigmentfläckar,